PBM Reforms: House Hearing Suggests Bipartisan Consensus On Legislative Policies Has Limits

There was lots of criticism of pharmacy benefit managers (and a fair amount aimed at pharmaceutical manufacturers) at the oversight hearing. However, Democrats may be more cautious about preserving the benefits PBMs provide versus the downsides in developing reforms.